SLIDES-AUDIO LECTURECMEABO MOC
Revelations in Retinal Vein Occlusion Management – What’s New?
|Author(s)/Faculty: Rishi P. Singh, MD; Michael S. Ip, MD; Yasha Modi, MD|
|Release Date: 6/30/2021||Expiration Date: 6/29/2022|
|Credit Type: CME / CME with ABO Continuing Certification ||Number of Credits: 0|
|Content Type: Lecture||Provider: |
|Retinal vein occlusions (RVOs) are the second leading cause of vision loss due to retinal vascular disease. New imaging technologies and potential biomarkers, along with the refinement of current diagnostic tools, are aiding in early and accurate diagnosis of RVO, allowing for timely initiation and monitoring of therapy. Therapeutic options for patients with RVO have also evolved, with clinical studies demonstrating that in patients with central or branch RVO-related macular edema, significant visual and anatomic improvements were reported in patients receiving intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. In this continuing medical education activity, experts in the field examine how innovations in imaging can improve the management of RVO and discuss how advances in the treatment of RVO achieved in clinical studies can be applied to real-world practice.|